Titel: Gene Therapy - Ready for the Market?

Termin: 30.1.2019, 10:00 Uhr, bis 31.1.2019, 16:15 Uhr

Veranstaltungsort:
DECHEMA e.V.
Society for Chemical Engineering and Biotechnology
Theodor-Heuss-Allee 25
60486 Frankfurt am Main

Referenten: Christian J. Buchholz (Paul-Ehrlich-Institut, Langen/D) *** Hildegard Büning (Hannover Medical School, Hannover/D) *** John Campbell (Scottish National Blood Transfusion Center, Edinburgh/UK) *** Klaus Cichutek (Paul-Ehrlich-Institut, Langen/D) *** Markus Hörer (Freeline Therapeutics GmbH, Planegg-Steinkirchen/D) *** Amine Kamen (McGill University, Montreal/CAN) *** Ulrike Köhl (Fraunhofer-Institut für Zelltherapie und Immunologie IZ, Leipzig/D) *** Otto Merten (Miltenyi Biotec Europe GmbH, Paris/F) *** Axel Schambach (Hannover Medical School, Hannover/D)

Weitere Informationen:
https://dechema.de/en/genetherapy2019.html

Kurzbeschreibung: The last years were very promising for gene therapeutic approaches. A number of successful treatments of cancer or rare diseases were reported, as well as FDA approval of first gene therapeutic products. Until now, these pioneering treatments have been used primarily when conventional therapies reach their limits. Development, manufacturing, quality control and clinical application of gene therapeutic products are very challenging and still far from routine.

The conference addresses the major issues on the way to save and successful products: “Gene Therapy - Ready for the Market?”.

Conference Topics:

- Manufacturing and quality control of gene therapeutic products

- Genome editing for gene therapy development

- Development and manufacturing of gene transfer vectors

- Manufacturing of cell-based gene therapeutic products

- Viral vectors for vaccination

- Clinical applications of gene therapeutic products

- Regulatory pathways to enable gene therapy

We are proud to announce renowned international Keynote Speakers.

You would still like to submit a last minute poster? Please contact silke.rumpf@dechema.de.



The conference is an initiative of the DECHEMA working groups Cell Culture Technology and Medical Biotechnology.

Kontakt: Silke Rumpf
DECHEMA e.V.
Theodor-Heuss-Allee 25
60486 Frankfurt am Main
Tel.: +49 (0)69 7564-280
silke.rumpf@dechema.de
http://www.dechema.de

Schlagworte: Gentherapie